News & Events

Promising FTD Gene Therapy from AviadoBio Featured in the UK Guardian

In London’s Docklands, British biotech company AviadoBio is developing a promising gene therapy to treat FTD. The Guardian wrote about the company’s progress on June 13. AviadoBio’s lead therapy, AVB-101,…

MORE

FTD Science Digest: Help Advance Science by Joining the Updated FTD Disorders Registry

It is a pivotal time for FTD clinical research. New therapies have advanced to phase 3 clinical trials. Treatments for FTD caused by variants in specific genes are closer than…

MORE

FTD Research Spotlight: A New Researcher Portal and Other Updates from the FTD Disorders Registry

It is a pivotal time for FTD clinical research. New therapies have advanced to phase 3 clinical trials. Treatments for FTD caused by variants in specific genes are closer than…

MORE

AFTD Webinar: Speech Language Therapy — A Promising Practice in FTD Treatment and Care

When patients lose the ability to communicate effectively, doctors and other clinicians often refer them to a speech language pathologist (SLP) to help them regain their speaking skills. But for…

MORE

The Lived Experience of FTD: The Challenges of July Fourth

The following article was written by former Persons with FTD Advisory Council member Cindy Odell. The Council works to ensure the voice of people living with FTD guides AFTD as…

MORE

Chinese Study Explores the Psychological Well-being and Health of Dementia Caregivers

A study published in the journal BMC Geriatrics explores the self-assessed well-being of informal care partners and professional caregivers who support people with dementia, such as FTD. The study provides…

MORE

“Alzheimer’s & Dementia” Publishes Summary of AFTD’s 2022 Holloway Summit

Digital health technologies have the potential to benefit the FTD community by improving accessibility to research and clinical care. Such technologies were the focus of the 2022 Holloway Summit —…

MORE

Leonard A. Lauder, 1933-2025

Leonard A. Lauder, a legend of the cosmetics industry who invested hundreds of millions of dollars into research seeking a cure for FTD and other dementias through his Alzheimer’s Drug…

MORE